- Home
- CODX vs PTN Comparison
CODX vs PTN Comparison
Compare CODX & PTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODX
- PTN
- Stock Information
- Founded
- CODX 2013
- PTN 1986
- Country
- CODX United States
- PTN United States
- Employees
- CODX N/A
- PTN N/A
- Industry
- CODX Medical/Dental Instruments
- PTN Biotechnology: Pharmaceutical Preparations
- Sector
- CODX Health Care
- PTN Health Care
- Exchange
- CODX Nasdaq
- PTN Nasdaq
- Market Cap
- CODX 22.0M
- PTN 25.4M
- IPO Year
- CODX 2017
- PTN 1993
- Fundamental
- Price
- CODX $0.48
- PTN $0.76
- Analyst Decision
- CODX Hold
- PTN Strong Buy
- Analyst Count
- CODX 1
- PTN 1
- Target Price
- CODX $1.50
- PTN $7.00
- AVG Volume (30 Days)
- CODX 199.5K
- PTN 527.6K
- Earning Date
- CODX 05-08-2025
- PTN 02-13-2025
- Dividend Yield
- CODX N/A
- PTN N/A
- EPS Growth
- CODX N/A
- PTN N/A
- EPS
- CODX N/A
- PTN N/A
- Revenue
- CODX $7,321,012.00
- PTN $350,000.00
- Revenue This Year
- CODX N/A
- PTN N/A
- Revenue Next Year
- CODX N/A
- PTN N/A
- P/E Ratio
- CODX N/A
- PTN N/A
- Revenue Growth
- CODX 57.16
- PTN N/A
- 52 Week Low
- CODX $0.46
- PTN $0.68
- 52 Week High
- CODX $2.23
- PTN $2.88
- Technical
- Relative Strength Index (RSI)
- CODX 31.25
- PTN 32.88
- Support Level
- CODX $0.46
- PTN $0.82
- Resistance Level
- CODX $0.68
- PTN $0.94
- Average True Range (ATR)
- CODX 0.07
- PTN 0.08
- MACD
- CODX 0.00
- PTN -0.01
- Stochastic Oscillator
- CODX 12.00
- PTN 11.04
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
About PTN Palatin Technologies Inc.
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with significant unmet medical need and commercial potential.